Diplasmenylcholine-folate liposomes: An efficient vehicle for intracellular drug delivery

Journal of the American Chemical Society

Volumn 120, Issue 44, 1998, Pages 11213-11218

  Rui, Yuanjin ^a   Wang, Susan ^a   Low, Philip S ^a   Thompson, David H ^a  

^a PURDUE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDES; ASSAYS; CONTROLLED DRUG DELIVERY; DNA; ENCAPSULATION; FLUORESCENCE; HYDROLYSIS; LIPIDS; PH; PLASMA STABILITY;

DIPLASMENYLCHOLINE; FOLATE LIPOSOMES; GLYCEROPHOSPHOCHOLINE; PROPIDIUM IODIDE; VINYL ETHER LIPID;

DRUG PRODUCTS;

CALCEIN; CHOLINE DERIVATIVE; CYTARABINE; DIPLASMENYLCHOLINE; DRUG CARRIER; DRUG VEHICLE; FOLIC ACID; LIPOSOME; PROPIDIUM IODIDE; UNCLASSIFIED DRUG;

ARTICLE; CYTOPLASM; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG STABILITY; ENCAPSULATION; GENE THERAPY; MEMBRANE TRANSPORT; PLASMA; TARGET CELL;

EID: 0032508960     PISSN: 00027863     EISSN: None     Source Type: Journal    
DOI: 10.1021/ja9742949     Document Type: Article

References (42)

1. Lee, R. J.; Huang, L. In Artificial Self-Assembling Systems for Gene Delivery; ACS Conference Proceedings Series, American Chemical Society: Washington, D.C., 1996; pp 169-176.
2. Liposomes in Gene Delivery; Lasic, D. D., Ed., Marcel Dekker: New York, 1997.
3. Hughes, B. J.; Kennel, S.; Lee, R.; Huang, L. Cancer Res. 1989, 49, 6214-6220.
4. Loughrey, H. C.; Wong, K. F.; Choi, L. S.; Cullis, P. R.; Bally, M. B. Biochim. Biophys. Acta 1990, 1028, 73-81.
5. Morgan, J.; MacRobert, A. J.; Gray, A. G.; Huehns, E. R. Br. J. Cancer 1992, 65, 58-64.
6. Lee, K.-D.; Hong, K.; Papahadjopoulos, D. Biochim. Biophys. Acta 1992, 1103, 185-197.
7. Leserman, L.; Suzuki, H.; Machy, P. Liposome Technology. 2nd ed.; Gregoriadis, G., Ed.; CRC Press: Boca Raton, FL, 1993; Vol. III, p 139-152.
8. Mori, A.; Huang, L. Liposome Technology. 2nd ed.; Gregoriadis, G., Ed.; CRC Press: Boca Raton, FL, 1993; Vol. III, p 153-162.
9. Lundberg, B.; Hong, K.; Papahadjopoulos, D. Biochim. Biophys. Acta 1993, 1149, 305-312.
10. Ahmad, I.; Longenecker, M.; Samuel, J.; Allen, T. M. Cancer Res. 1993, 53, 1484-1488.
11. Wang, S.; Lee, R. J.; Cauchon, G.; Gorenstein, D. G.; Low, P. S. Proc. Natl. Acad. Sci. U.S.A. 1995, 92, 3318-3322.
12. Stealth Liposomes; Lasic, D. D., Martin, F. J., Eds.; CRC Press: Boca Raton, FL, 1995.
13. Mayer, L. D.; Tai, L. C. L.; Ko, D. S. C.; Masin, D.; Ginsberg, R. S.; Cullis, P. R.; Bally, M. B. Cancer Res. 1989, 49, 5922-5930.
14. Mayhew, E. G.; Lasic, D.; Babbar, S.; Martin, F. J. Int. J. Cancer 1992, 51, 302-309.
15. Vaage, J.; Mayhew, E.; Lasic, D.; Martin, F. Int. J. Cancer 1992, 51, 942-948.
16. Huang, S. K.; Lee, K.-D.; Hong, K.; Friend, D. S.; Papahadjopoulos, D. Cancer Res. 1992, 52, 5135-5143.
17. Yuan, F.; Leunig, M.; Huang, S. K.; Berk, D. A.; Papahadjopoulos, D.; Jain, R. K. Cancer Res. 1994, 54, 3352-3356.
18. Gerasimov, O. V.; Rui, Y.; Thompson, D. H. Vesicles; Rosoff, M., Ed.; Marcel Dekker: New York, 1996; pp 679-746.
19. Gerasimov, O. V.; Boomer, J. A.; Qualls, M. M.; Thompson, D. H. Adv. Drug Delivery Rev. 1998, in press.
20. Kovesdi, I.; Brough, D. E.; Bruder, J. T.; Wickham, T. J. Curr. Opin. Biotechnol. 1997, 8, 583-589.
21. Dijkstra, J.; Bron, R.; Wilschut, J.; deHaan, A.; Ryan, J. L. J. Immunology 1996, 157, 1028-1036.
22. Lee, R. J.; Low, P. S. J. Biol. Chem. 1994, 269, 3198-3204.
23. Smith, M. D., Ph.D. Thesis, Purdue University, 1997.
24. Rui, Y.; Thompson, D. H. Chem. Eur. J. 1996, 2, 1505-1508.
25. Rui, Y.; Thompson, D. H. J. Org. Chem. 1994, 59, 5758-5762.
26. Thompson, D. H.; Gerasimov, O. V.; Wheeler, J. J.; Rui, Y.; Anderson, V. C. Biochim. Biophys. Acta 1996, 1279, 25-34.
27. Gerasimov, O. V.; Wymer, N.; Miller, D.; Rui, Y.; Thompson, D. H. ACS Symp. Ser., in press.
28. Wymer, N.; Gerasimov, O. V.; Thompson, D. H. Bioconjugate Chem. 1998, 9, 305-308.
29. Similar release kinetics were observed when cholesterol was used instead of DHC.
30. Lee, R. J., Ph.D. Thesis, Purdue University, 1994.
31. Gerasimov, O. V.; Schwan, A.; Thompson, D. H. Biochim. Biophys. Acta 1997, 1324, 200-214.
32. 1H NMR in the isolated organic soluble fraction from Bligh-Dyer extraction, these partially hydrolyzed species must be cleaved more rapidly than their diplasmenylcholine precursors.
33. Vogel, K.; Wang, S.; Lee, R. J.; Chmielewski, J.; Low, P. S. J. Am. Chem. Soc. 1996, 118, 1581-1586.
34. The efficacy of Ara-C, the most commonly used drug for the treatment of human acute myeloid leukemia, is limited by low lipophilicity and a host of other biologic factors. Several prodrug approaches have been investigated to enhance its activity: Wipf, P.; Li, W. Drugs Future 1994, 19, 49-54.
35. Brown, P. M.; Silvius, J. R. Biochim. Biophys. Acta 1990, 1023, 341-351.
36. Conner, J.; Huang, L. Cancer Res. 1986, 46, 3431-3435.
37. Ho, R. J. Y.; Rouse, B. T.; Huang, L. J. Biol. Chem. 1987, 262, 13973-13978.
38. Schwendener, R. A.; Schott, H. Int. J. Cancer 1992, 51, 466-469.
39. Allen, T. M.; Mehra, T.; Hansen, C.; Chin, Y. C. Cancer Res. 1992, 52, 2431-2439.
40. Qualls, M. M.; Thompson, D. H., unpublished results.
41. Szleifer, I.; Gerasimov, O. V.; Thompson, D. H. Proc. Natl. Acad. Sci. U.S.A. 1998, 95, 1032-1037.
42. Mayer, L. D.; Hope, M. J.; Cullis, P. R. Biochim. Biophys. Acta 1986, 858, 161-168.